CytoDyn (CYDY) Interest & Investment Income (2011 - 2026)
CytoDyn (CYDY) posted Interest & Investment Income of $15000.0 for Q1 2026, down 73.68% on a QoQ basis from $57000.0 in Q4 2025, and down 91.33% year-over-year from $173000.0 in Q1 2025.
CytoDyn (CYDY) Interest & Investment Income (2011 - 2026) Analysis & Trends
CytoDyn's Interest & Investment Income history runs 14 years deep, the most recent figure standing at $15000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 91.33% year-over-year to $15000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $290000.0 (down 34.24% YoY) and the FY2025 annual result came in at $565000.0, up 160.37% from the prior year.
- Interest & Investment Income was $15000.0 for Q1 2026 at CytoDyn, down from $57000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $173000.0 in Q1 2025 and bottomed at $15000.0 in Q1 2026.
- A 3-year average of $104428.6 and a median of $124000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income retreated 25.4% — and 2026, when it slumped 91.33%.
- CytoDyn's Interest & Investment Income stood at $142000.0 in 2024, then sank by 59.86% to $57000.0 in 2025, then sank by 73.68% to $15000.0 in 2026.
- Business Quant data shows CYDY's Interest & Investment Income at $15000.0 in Q1 2026, $57000.0 in Q4 2025, and $94000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | CytoDyn | 258.22 Mn | 258.22 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 15,000.00 |
| Nov 30, 2025 | 57,000.00 |
| Aug 31, 2025 | 94,000.00 |
| May 31, 2025 | 124,000.00 |
| Feb 28, 2025 | 173,000.00 |
| Nov 30, 2024 | 142,000.00 |
| Aug 31, 2024 | 126,000.00 |
| Feb 28, 2021 | 1,000.00 |
| Feb 29, 2020 | 3,000.00 |
| Nov 30, 2019 | 2,000.00 |
| May 31, 2019 | 1,979.00 |
| Feb 28, 2019 | 19.00 |
| Nov 30, 2018 | 1,021.00 |
| Aug 31, 2018 | 979.00 |
| May 31, 2018 | 1,750.00 |
| Feb 28, 2018 | 662.00 |
| Nov 30, 2017 | 422.00 |
| Aug 31, 2017 | 787.00 |
| May 31, 2017 | 2,196.00 |
| Feb 28, 2017 | 3,588.00 |